1276.1.33004 Boehringer Ingelheim Investigational Site

Behren-lès-Forbach

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2, Hyperglycemia

Studies at this site

• Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes — Completed